CAMP4 Therapeutics’ Post

Because the patient can't wait, it's critical for leaders to create a culture of speed and urgency in drup and therapy development. Listen to Pete O'Heeron from FibroBiologics describe creating a culture of urgency and speed to get to the patient quicker and reduce the cost. Listen to our full podcast conversation at one of the links in the first comment. #ceo #servantleadership #lifescience

In all of healthcare and life science, there is a patient at the end of every conversation or experiment. Forgetting that is doing a disservice to your people and the patient. Listen as Pete O'Heeron from FibroBiologics describes the power of this truth for him and his team. Listen to our full podcast conversation at one of the links in the first comment. #ceo #lifescience #servantleadership

For our last episode of the year (!), Damian, Adam, and I recapped the year in biotech, the best and worst CEOs, and, honestly, got a little goofy. Thank you to everyone who listens each week. We'll have more episodes coming for you in January! #biotech #pharma #2023 #yearinreview #yearendreflections #podcast

Lab owners and Executives, you will not want to miss our new Podcast, The End Game, Laboratory Insiders on your side coming in January! #mergersandacquisitions #ASP #molecularbiology #moleculardiagnostics #pathologylab #laboratory

🎙️ Podcast Alert: Navigating IND Applications & Pre-IND Meetings: Key Considerations And Misconceptions Listen now: https://ow.ly/nLIX50Siuvs In this podcast, glean insights from an experienced regulatory leader at Allucent and an expert currently navigating the complexities of the pre-IND stage at Ridgeline Therapeutics. They dive into best practices for pre-IND meetings and IND applications, helping you develop strategies to succeed in this increasingly challenging environment. #INDApplications #PharmaPodcast #DrugDevelopment #BiotechTalk #ClinicalTrials #FDAGuidance #RegulatoryAffairs #HealthcareInnovation

The 5th episode of our series, "Why SciY," hosted by Mestrelab's CEO, Santi Dominguez, featuring guest Dr. Guy Desmarquets, Senior Director of Sales and Business Develpment at SciY. Check out the sneak peek and stay tuned! 🎧 Listen to our previous episodes here: 👉 https://bit.ly/4bY5aWr #MnovaRocks #Mnova #labautomation #analyticalchemistry #NMRchat #DatAautomation #automationworkflow #pharma #biotech #chemistry #medicinalchemistry #podcast

🎙️ Podcast Alert: Navigating IND Applications & Pre-IND Meetings: Key Considerations And Misconceptions Listen now: https://ow.ly/VzWX50SiuzW In this podcast, glean insights from an experienced regulatory leader at Allucent and an expert currently navigating the complexities of the pre-IND stage at Ridgeline Therapeutics. They dive into best practices for pre-IND meetings and IND applications, helping you develop strategies to succeed in this increasingly challenging environment. #INDApplications #PharmaPodcast #DrugDevelopment #BiotechTalk #ClinicalTrials #FDAGuidance #RegulatoryAffairs #HealthcareInnovation

Commuting to work? Taking the sun at the beach? If you have some time to spare, listen to the latest episode of The Single Cell World podcast to learn everything you always wanted to know about BD Rhapsody™ but never dared to ask. Performance without compromises. Especially on budget! #epigenomics #atacseq #singlecellmultiomics #BDRhapsody #BDBiosciences

Thank you, Citeline Commercial, for your podcast interviewing our CEO and Co-Founder, Joel Morse, as well as our partners, Andy Molnar, CEO of Digital Therapeutics Alliance, and Owen McCarthy, CEO of MedRhythms, Inc.! Give the podcast a listen to hear the trio discuss the current situation surrounding #digitaltherapeutics, and where they believe they are headed in the coming years. #DTx #clinicalresearch #DCTs https://lnkd.in/gErsWZvJ